Results 231 to 240 of about 13,442,224 (337)
Effect of chemotherapy on passenger mutations in metastatic colorectal cancer
Changes in passenger mutation load and predicted immunotherapy response after chemotherapy treatment. Tumor cells rich with passenger mutations have increased sensitivity to chemotherapy. Correlation of passenger mutations with neoantigen load suggests highly mutated clones promote a more effective response to immunotherapy, and therefore, first‐line ...
Marium T. Siddiqui +6 more
wiley +1 more source
Contributors to the 2025 <i>RSC Chemical Biology</i> Emerging Investigators Collection. [PDF]
europepmc +1 more source
Women's experiences collecting and accessing water in Guatemala, Honduras, Kenya, and Zimbabwe: A mixed-methods investigation. [PDF]
Caruso BA +29 more
europepmc +1 more source
Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells
Despite the strong activity of selective RET tyrosine kinase inhibitors (TKIs), resistance of RET fusion‐positive (RET+) lung cancer and thyroid cancer frequently occurs and is mainly driven by RET‐independent bypass mechanisms. Son et al. show that SRC TKIs significantly inhibit PAK and AKT survival signaling and enhance the efficacy of RET TKIs in ...
Juhyeon Son +13 more
wiley +1 more source
Mozambique's Colonial-Era Non-Human Primate Collection at the National Museum of Natural History and Science of Lisbon: Taxonomy, Provenance, and Historical Context. [PDF]
Osório M, Veracini C.
europepmc +1 more source
Generation of two normal and tumour (cancerous) paired human cell lines using an established tissue culture technique and their characterisation is described. Cell lines were characterised at cellular, protein, chromosome and gene expression levels and for HPV status.
Simon Broad +12 more
wiley +1 more source
A 10-step guide to standardising patient-reported outcomes data collection in healthcare: insights from the health outcomes observatory (H2O) project on overcoming implementation barriers. [PDF]
Galan G +16 more
europepmc +1 more source

